SALT LAKE CITY, Utah, Oct. 29, 2019 /PRNewswire/ -- Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results